How a joined-up development strategy pays off for early-stage biotechs
Parexel Biotech’s Nate Akers and Vicky Hsu discuss how important it is for biotechs to align clinical execution with a clearly defined regulatory strategy to increase the chance of success for a new drug program.
Related Insights
Article
8 things you need to know about eCTDs in China
Jul 1, 2022
Webinar
Accelerating delivery of radiopharmaceutical trials
Oct 3, 2025
Webinar
Assessing appropriate use of ECAs in clinical trials
May 28, 2023
Blog
Studying multiple versions of a cellular or gene therapy product in an early-phase clinical trial
Nov 19, 2021
Podcast
Enabling Successful Sites, Episode 2: Empowering Sites to be More Inclusive Through Cultural Sensitivity Training
Jun 28, 2024
Video
Part 3: Risk-based Quality Management Video (RBQM) Series
Nov 11, 2021
Video
Part 2: Risk-based Quality Management Video (RBQM) Series
Nov 11, 2021
Report
New Medicines, Novel Insights: Accelerating development of cell and gene therapies
May 22, 2023
Article
Expedited Pathways Comparisons - US EU CHN
Oct 19, 2021
Report
New Medicines, Novel Insights: Advancing rare disease drug development
May 22, 2023
Playbook
Streamlining development in the EU: Strategies for smoother CTA submissions
Feb 27, 2025
Article
Part 1 - Preparing for a Risk-Based Future: What ICH Revisions Mean for Clinical Trial Design and Conduct
Sep 14, 2021
Related Insights
Article
8 things you need to know about eCTDs in China
Jul 1, 2022
Webinar
Accelerating delivery of radiopharmaceutical trials
Oct 3, 2025
Webinar
Assessing appropriate use of ECAs in clinical trials
May 28, 2023
Blog
Studying multiple versions of a cellular or gene therapy product in an early-phase clinical trial
Nov 19, 2021
Podcast
Enabling Successful Sites, Episode 2: Empowering Sites to be More Inclusive Through Cultural Sensitivity Training
Jun 28, 2024
Video
Part 3: Risk-based Quality Management Video (RBQM) Series
Nov 11, 2021
Video
Part 2: Risk-based Quality Management Video (RBQM) Series
Nov 11, 2021
Report
New Medicines, Novel Insights: Accelerating development of cell and gene therapies
May 22, 2023
Article
Expedited Pathways Comparisons - US EU CHN
Oct 19, 2021
Report
New Medicines, Novel Insights: Advancing rare disease drug development
May 22, 2023
Playbook
Streamlining development in the EU: Strategies for smoother CTA submissions
Feb 27, 2025
Article
Part 1 - Preparing for a Risk-Based Future: What ICH Revisions Mean for Clinical Trial Design and Conduct
Sep 14, 2021